"10.1371_journal.pone.0088340","plos one","2014-02-11T00:00:00Z","Annett Hessel; Helga Savidis-Dacho; Sogue Coulibaly; Daniel Portsmouth; Thomas R Kreil; Brian A Crowe; Michael G Schwendinger; Andreas Pilz; P Noel Barrett; Falko G Falkner; Birgit Sch√§fer","Vaccine R&D, Baxter Bioscience, Orth/Donau, Austria; Pharmacology, Baxter Bioscience, Orth/Donau, Austria; Global Pathogen Safety, Baxter Bioscience, Vienna, Austria; Biologicals R&D, Baxter Bioscience, Orth/Donau, Austria","Conceived and designed the experiments: AH TRK BAC MGS PNB FGF BS. Performed the experiments: AH HSD SC MGS AP BS. Analyzed the data: AH HSD SC DP TRK BAC MGS AP PNB FGF BS. Wrote the paper: AH HSD SC DP TRK BAC MGS AP PNB FGF BS.","AH, BS, HS-D, SC, DP, TRK, BAC, MGS, AP, PNB and FGF report being employed by Baxter. HS-D, SC, TRK, BAC, MGS, PNB and FGF report having an equity interest in the company. AH, BS, TRK, PNB and FGF report a submitted patent on MVA vectors: Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A virses WO 2012/106231; PCT/US2012/023085. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","02","Annett Hessel","AH",11,TRUE,7,6,11,11,TRUE,TRUE,FALSE,0,NA,FALSE
